Literature DB >> 15630646

Prophylactic antibiotic use in pediatric burn units.

O Ergün1, A Celik, G Ergün, G Ozok.   

Abstract

Prophylactic antibiotic use in childhood burns is controversial. The efficiency of antibiotic prophylaxis in 77 pediatric burn patients was evaluated. Forty-seven patients received prophylactic antibiotics (Group AP), while 30 patients received no prophylaxis (Group NP). Age, wound depth, day of admission, mechanism of burn injury, type of dressings were similar for both groups (p > 0.05). Wound infection rates were 21.3 % in Group AP and 16.7 % in Group NP (p > 0.05). S. aureus, Enterobacter spp., P. aeruginosa, and E. coli were the most common microorganisms. Patients with wound colonization and infection had a larger burned total body surface area (BTBSA) in both groups (p < 0.01). Eight patients had clinical sepsis. All but one of the septic patients were from Group AP. Associated infections of the upper and lower respiratory tract (16), urinary tract (7), and otitis media (2) were more common in Group AP. One patient died from sepsis in Group AP. Hospital stays were longer in Group AP (21.7 +/- 16.4 vs. 13.5 +/- 10 days; p < 0.05). Antibiotic prophylaxis in childhood burns does not reduce the rate of wound infection. Age, wound depth and BTBSA are not critical variables for prophylaxis. Reinforcing the use of culture-specific antibiotics for more beneficial and cost-effective results in the treatment of childhood burns is recommended.

Entities:  

Mesh:

Year:  2004        PMID: 15630646     DOI: 10.1055/s-2004-821065

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  8 in total

Review 1.  [Antimicrobial treatment in burn injury patients].

Authors:  T Trupkovic; J Gille; H Fischer; S Kleinschmidt
Journal:  Anaesthesist       Date:  2012-03       Impact factor: 1.041

2.  Sociodemographic and culture results of paediatric burns.

Authors:  Muhammet Asena; Pinar Aydin Ozturk; Unal Ozturk
Journal:  Int Wound J       Date:  2019-11-03       Impact factor: 3.315

Review 3.  Ichthyosis in the newborn.

Authors:  Brittany G Craiglow
Journal:  Semin Perinatol       Date:  2013-02       Impact factor: 3.300

Review 4.  Burn wound infections.

Authors:  Deirdre Church; Sameer Elsayed; Owen Reid; Brent Winston; Robert Lindsay
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

5.  Surgical Antimicrobial Prophylaxis in Pediatric Patients Undergoing Plastic Surgery: A RAND/UCLA Appropriateness Method Consensus Study.

Authors:  Susanna Esposito; Rossella Sgarzani; Sonia Bianchini; Sara Monaco; Laura Nicoletti; Erika Rigotti; Marilia Di Pietro; Roberta Opri; Caterina Caminiti; Matilde Ciccia; Giorgio Conti; Daniele Donà; Mario Giuffré; Stefania La Grutta; Laura Lancella; Mario Lima; Andrea Lo Vecchio; Gloria Pelizzo; Giorgio Piacentini; Carlo Pietrasanta; Matteo Puntoni; Alessandro Simonini; Elisabetta Venturini; Annamaria Staiano; Nicola Principi
Journal:  Antibiotics (Basel)       Date:  2022-04-11

Review 6.  Routine systemic antibiotic prophylaxis for burn injuries in developing countries: A best evidence topic (BET).

Authors:  Barclay T Stewart; Adam Gyedu; Pius Agbenorku; Richcane Amankwa; Adam L Kushner; Nicole Gibran
Journal:  Int J Surg       Date:  2015-08-07       Impact factor: 6.071

7.  Inhibition of Pseudomonas aeruginosa with a recombinant RNA-based viral vector expressing human β-defensin 4.

Authors:  Sehee Park; Jin Il Kim; Ilseob Lee; Joon-Yong Bae; Min-Woong Hwang; Donghwan Kim; Seok-Il Jang; Hyejin Kim; Mee Sook Park; Hyung-Joo Kwon; Jin-Won Song; Yong Suk Cho; Wook Chun; Man-Seong Park
Journal:  BMC Microbiol       Date:  2014-09-27       Impact factor: 3.605

8.  Systemic antibiotic prophylaxis does not affect infectious complications in pediatric burn injury: A meta-analysis.

Authors:  Alexandra Csenkey; Gergo Jozsa; Noemi Gede; Eszter Pakai; Benedek Tinusz; Zoltan Rumbus; Anita Lukacs; Zoltan Gyongyi; Peter Hamar; Robert Sepp; Andrej A Romanovsky; Peter Hegyi; Peter Vajda; Andras Garami
Journal:  PLoS One       Date:  2019-09-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.